ArticleBMJ open2018
Population-based analysis of patients with COPD in Catalonia: a cohort study with implications for clinical management.
Article in BMJ open, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02956395 (Protocol for Regional Implementation of Community-based Collaborative Management of Complex Chronic Patients), which is not on this map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Protocol for Regional Implementation of Community-based Collaborative Management of Complex Chronic Patients (CCP)
Who cites it
13 citing papers in PubMed, 28 citations in OpenAlex.
- Should household air quality monitoring be considered in selected patients with asthma and COPD?BMJ open respiratory research · 2026Observational
- Article
- Prognostic Models for Disease Progression and Outcomes in Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.Journal of clinical medicine · 2025Review
- Protocol for the enhanced management of multimorbid patients with COPD and severe asthma: role of indoor air quality.BMJ open respiratory research · 2025Observational
- Prevention of Unplanned Hospital Admissions in Multimorbid Patients Using Computational Modeling: Observational Retrospective Cohort Study.Journal of medical Internet research · 2023Observational
- Prospective cohort study for assessment of integrated care with a triple aim approach: hospital at home as use case.BMC health services research · 2022Article
- Healthcare costs of patients with chronic obstructive pulmonary disease in Denmark - specialist care versus GP care only.BMC health services research · 2022Article
- Number of Teeth and All-Cause and Cancer Mortality in a Japanese Community: The Takayama Study.Journal of epidemiology · 2020Article
- ERS Presidential Summit 2018: multimorbidities and the ageing population.ERJ open research · 2019Review
- Evaluation of integrated care services in Catalonia: population-based and service-based real-life deployment protocols.BMC health services research · 2019Article
- Observational
- Risk and temporal order of disease diagnosis of comorbidities in patients with COPD: a population health perspective.BMJ open respiratory research · 2018Article
- Toward Adoption of Health Risk Assessment in Population-Based and Clinical Scenarios: Lessons From JADECARE.International journal of integrated careArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 5 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundClinical management of patients with chronic obstructive pulmonary disease (COPD) shows potential for improvement provided that patients' heterogeneities are better understood. The study addresses the impact of comorbidities and its role in health risk assessment.
objectiveTo explore the potential of health registry information to enhance clinical risk assessment and stratification.
designFixed cohort study including all registered patients with COPD in Catalonia (Spain) (7.5 million citizens) at 31 December 2014 with 1-year (2015) follow-up.
methodsA total of 264 830 patients with COPD diagnosis, based on the International Classification of Diseases (Ninth Revision) coding, were assessed. Performance of multiple logistic regression models for the six main dependent variables of the study: mortality, hospitalisations (patients with one or more admissions; all cases and COPD-related), multiple hospitalisations (patients with at least two admissions; all causes and COPD-related) and users with high healthcare costs. Neither clinical nor forced spirometry data were available.
resultsMultimorbidity, assessed with the adjusted morbidity grouper, was the covariate with the highest impact in the predictive models, which in turn showed high performance measured by the C-statistics: (1) mortality (0.83), (2 and 3) hospitalisations (all causes: 0.77; COPD-related: 0.81), (4 and 5) multiple hospitalisations (all causes: 0.80; COPD-related: 0.87) and (6) users with high healthcare costs (0.76). Fifteen per cent of individuals with highest healthcare costs to year ratio represented 59% of the overall costs of patients with COPD.
conclusionsThe results stress the impact of assessing multimorbidity with the adjusted morbidity grouper on considered health indicators, which has implications for enhanced COPD staging and clinical management. TRIAL REGISTRATION NUMBER: NCT02956395.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.